Cancer Genetics and Epigenetics 2024, Vol.12, No.5, 279-293 http://medscipublisher.com/index.php/cge 290 Easton D.F., Deffenbaugh A.M., Pruss D., Frye C., Wenstrup R.J., Allen-Brady K., Tavtigian S.V., Monteiro A.N.A., Iversen E.S., Couch F.J., and Goldgar D.E., 2007, A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes, American Journal of Human Genetics, 81(5): 873-883. https://doi.org/10.1086/521032 PMID: 17924331 PMCID: PMC2265654 Economopoulou P., Dimitriadis G., and Psyrri A., 2015, Beyond BRCA: new hereditary breast cancer susceptibility genes, Cancer Treatment Reviews, 41(1): 1-8. https://doi.org/10.1016/j.ctrv.2014.10.008 PMID: 25467110 Foley S.B., Rios J.J., Mgbemena V.E., Robinson L.S., Hampel H.L., Toland A.E., Durham L., and Ross T.S., 2014, Use of whole genome sequencing for diagnosis and discovery in the cancer genetics clinic, EBioMedicine, 2(1): 74-81. https://doi.org/10.1016/j.ebiom.2014.12.003 PMID: 26023681 PMCID: PMC4444225 Ginsburg O., Yip C., Brooks A., Cabanes A., Caleffi M., Yataco J., Gyawali B., McCormack V., Anderson M., Mehrotra R., Mohar A., Murillo R., Pace L., Paskett E., Romanoff A., Rositch A., Scheel J., Schneidman M., Unger-Saldaña K., Vanderpuye V., Wu T., Yuma S., Dvaladze A., Duggan C., and Anderson B., 2020, Breast cancer early detection: A phased approach to implementation, Cancer, 126. https://doi.org/10.1002/cncr.32887 Gorgannezhad L., Umer M., Islam M., Nguyen N., and Shiddiky M., 2018, Circulating tumor DNA and liquid biopsy: opportunities, challenges, and recent advances in detection technologies, Lab on a Chip, 18(8): 1174-1196. https://doi.org/10.1039/C8LC00100F Haferlach C., Walter W., Meggendorfer M., Stengel A., Baer C., Hutter S., Nadarajah N., Müller H., Kern W., and Haferlach T., 2021, Benchmarking of whole genome sequencing (WGS) and whole transcriptome sequencing (WTS) as diagnostic tools for the genetic characterization of acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) in adults, Blood, 138(1): 273. https://doi.org/10.1182/blood-2021-150260 Heitzer E., Ulz P., and Geigl J., 2015, Circulating tumor DNA as a liquid biopsy for cancer, Clinical Chemistry, 61(1): 112-123. https://doi.org/10.1373/clinchem.2014.222679 Huang H., 2024, Case-based analysis of breast cancer immunotherapy: efficacy, challenges, and future directions, International Journal of Clinical Case Reports, 14(3): 167-177. https://doi.org/10.5376/ijccr.2024.14.0018 Jia G.C., Lu Y., Wen W., Long J., Liu Y., Tao R., Li B., Denny J., Shu X., and Zheng W., 2020, Evaluating the utility of polygenic risk scores in identifying high-risk individuals for eight common cancers, JNCI Cancer Spectrum, 4(3): pkaa021. https://doi.org/10.1093/jncics/pkaa021 PMID: 32596635 PMCID: PMC7306192 Jotwani A., and Gralow J., 2012, Early detection of breast cancer, Molecular Diagnosis and Therapy, 13: 349-357. https://doi.org/10.1007/BF03256340 Lambert S.A., Abraham G., and Inouye M., 2019, Towards clinical utility of polygenic risk scores, Human Molecular Genetics, 28(R2): R133-R142. https://doi.org/10.1093/hmg/ddz187 PMID: 31363735 Lebeau M., Kessler L., Guerra C., Krofah E., and Brain K., 2023, Health equity challenges facing testing, evaluation, and implementation of multi-cancer early detection tests, Journal of Clinical Oncology, 41(6): e15051. https://doi.org/10.1200/jco.2023.41.16_suppl.e15051 Lewis C.M., and Vassos E., 2020, Polygenic risk scores: from research tools to clinical instruments, Genome Medicine, 12(1): 44. https://doi.org/10.1186/s13073-020-00742-5 PMID: 32423490 PMCID: PMC7236300 Li J.X., Jia Z.Q., Zhang M., Liu G., Xing Z., Wang X., Huang X., Feng K., Wu J., Wang W., Wang J., Liu J., and Wang X., 2022, Cost-effectiveness analysis of imaging modalities for breast cancer surveillance among BRCA1/2 mutation carriers: a systematic review, Frontiers in Oncology, 11: 763161. https://doi.org/10.3389/fonc.2021.763161 PMID: 35083138 PMCID: PMC8785233 Liu J., Zhao H., Huang Y., Xu S., Zhou Y., Zhang W., Li J., Ming Y., Wang X., Zhao S., Li K., Dong X., Ma Y., Qian T., Chen X., Xing Z., Zhang Y., Chen H., Liu Z., Pang D., Zhou M., Wu Z., Wang X., Wang X., Wu N., and Su J., 2021, Genome-wide cell-free DNA methylation analyses improve accuracy of non-invasive diagnostic imaging for early-stage breast cancer, Molecular Cancer, 20(1): 36. https://doi.org/10.1186/s12943-021-01330-w MBUYA-BIENGE C., Pashayan N., Kazemali C., Lapointe J., Simard J., and Nabi H., 2023, A systematic review and critical assessment of breast cancer risk prediction tools incorporating a polygenic risk score for the general population, Cancers, 15(22): 5380. https://doi.org/10.3390/cancers15225380 Mohammadpour A., Jahangirian E., Moharrami T., Rad G., Sheikhani L., and Taghizadeh S., 2020, Breast cancer, genetic factors and methods of diagnosis, Sarem Journal of Reproductive Medicine, 103(3): e36905. https://doi.org/10.52547/sjrm.4.4.198
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==